US Stock MarketDetailed Quotes

NTLA Intellia Therapeutics

Watchlist
  • 23.595
  • +2.215+10.36%
Trading Jun 3 12:29 ET
2.28BMarket Cap-4393P/E (TTM)

Intellia Therapeutics Key Stats

Intellia Therapeutics Earnings Date

Currency: USD

Period

Q1 FY2024 Earnings

May 9, 2024

Revenue(YoY)

28.94M

+129.53%
EPS(YoY)

-1.12

+4.27%

Strong Buy

Jun 3, 2024

Intellia Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 21 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 10.564M--
--2024/Q2-- / 18.487M--
May 9, 20242024/Q128.935M / 9.065M--
Feb 22, 20242023/Q4-1.917M / 11.359M--
Nov 9, 20232023/Q311.992M / 11.953M--
Aug 3, 20232023/Q213.594M / 11.315M--
May 4, 20232023/Q112.606M / 11.122M--
Feb 23, 20232022/Q413.573M / 10.711M--
Nov 3, 20222022/Q313.266M / 10.930M--
Aug 4, 20222022/Q214.030M / 9.499M--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 10.564M--
--2024/Q2-- / 18.487M--
May 9, 20242024/Q128.935M / 9.065M--
Feb 22, 20242023/Q4-1.917M / 11.359M--
Nov 9, 20232023/Q311.992M / 11.953M--
Aug 3, 20232023/Q213.594M / 11.315M--
May 4, 20232023/Q112.606M / 11.122M--
Feb 23, 20232022/Q413.573M / 10.711M--
Nov 3, 20222022/Q313.266M / 10.930M--
Aug 4, 20222022/Q214.030M / 9.499M--

Unlock Free Earnings Estimates

Intellia Therapeutics Earnings Reports

Read more

Analysis

Analyst Rating

Updated: Jun 3, 2024

Strong Buy

  • Buy

    75.00%
  • Hold

    25.00%
  • Sell

    0.00%

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg